06 Mar Dalteparin for extended treatment of symptomatic venous thromboembolism in patients with cancer
Background information of the condition Venous thromboembolism (VTE) in patients with cancer: Cancer is a major risk factor for VTE with the 12-month cumulative incidence of recurrent VTE three times higher than patients without cancer [20.7%...